Disposition of morphine in rat brain: relationship to biological activity

GJ Plomp, RA Maes and JM van Ree

The levels of morphine in plasma and brain subcortex of rats were determined by gas-liquid chromatography and radioimmunoassay at various time intervals after a single i.v. injection of graded doses of morphine (0.44, 1.04 and 2.25 mg/kg). The disappearance curve of morphine plasma levels appeared to be composed of at least two exponential terms: a rapid disappearance during the 1st hr, which was dependent on the unit dose of morphine injected and a slower disappearance rate after the 1st hr. The highest morphine levels in the brain were measured already 5 min after its injection and these levels only slightly decreased over the next 2 hr. Thereafter a more rapid disappearance of brain morphine was observed. The brain/plasma ratio gradually increased from 0.18 at 5 min after injection to about 1.0 at 60 and 120 min and decreased to approximately 0.4 at 4 hr after injection. This may suggest that morphine is retained in the brain during the 1st hr after injection and that it might be removed from the brain between 2 and 4 hr, possibly by an active process. The relationship between brain morphine levels and the degree of antinociception as assessed with the hot plate procedure appeared to be rather complicated. Shortly after morphine injection, but also at 60 and 120 min after injection, the antinociceptive effect was much lower than might be expected from the levels of morphine in the brain. Several possible explanations for this phenomenon are discussed. A high dose of naltrexone, which completely blocked the antinociceptive effect of morphine, did not affect brain and plasma levels of morphine. Rifampicin, which attenuates development of morphine tolerance, increased brain levels of morphine but did not change plasma levels. Pretreatment with the tripeptide prolyl-leucyl-glycinamide, which facilitates development of morphine tolerance, decreased brain morphine levels and increased plasma levels at 3 hr after morphine injection. This suggests that tolerance development and the rate with which morphine is removed from the brain may have at least some common underlying mechanisms.

Volume 217, Issue 1, pp. 181-188, 04/01/1981
Copyright © 1981 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				S. P. Letrent, G. M. Pollack, K. R. Brouwer, and K. L.R. Brouwer Effects of a Potent and Specific P-Glycoprotein Inhibitor on the Blood-Brain Barrier Distribution and Antinociceptive Effect of Morphine in the Rat Drug Metab. Dispos., July 1, 1999; 27(7): 827 - 834. [Abstract] [Full Text]